PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General...
-
Upload
gertrude-dennis -
Category
Documents
-
view
216 -
download
0
Transcript of PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General...
PRURITUS
Catriona Mayland
July 2002
Topics
• Definition
• Neuroanatomy
• Mediators
• Evaluation
• General treatment
• Systemic disorders
• Specific treatment
Definition
• Unpleasant sensation causing desire to scratch
• Normally protective function
• Sensation arises from superficial skin, mucous membranes, conjunctiva
Neuroanatomy
• Nerve endings – dermo-epidermal junction
• Impulses – dorsal root ganglion
• Synapse in dorsal horn
• Efferents – contralateral spinothalamic tract
• Somatosensory cortex
• New concepts – peripheral & central mechanisms
Mediators
• Physical stimulation
• Chemical mediators– Amines e.g. histamine, serotonin, dopamine– Opiods e.g. met-enkephalin, -endorphin– Eicosanoids– Cytokines e.g. IL-1 to 11, TNF
And there’s more…
• Proteases e.g. tryptases, papain, kallikrein
• Growth Factor
• Neuropeptides– Substance P– CGRP, VIP, CCK– Bradykinin– Somatostatin, endothelin, neurokinin
Histamine
• Itching if applied to superficial damaged skin or injected intradermally
• Dermal mast cells
• Skin blood vessels, eccrine glands, basophils, hair follicles
Action
• Direct stimulation H receptors
• ? stimulation formulation other mediators
• Repeated injection – response decreases
• ? role in chronic itch
Serotonin
• Action– Direct on peripheral serotoninergic receptors– C-fibres via 5-HT3 receptors
Central Transmitters
• Endogenous opiods– Regulatory action– Both excitatory and modulatory effects– Inhibit presynaptic signals – modulate
secondary transmission– Abnormal central settings – directly trigger itch
despite no peripheral input
Other Mediators
• Exacerbate– Heat
– Anxiety
– Boredom
– Poor coping strategies
• Reduce– Cold
– Relaxation
– Distraction
– Good coping stategies
Evaluation
• Primary dermatological disease
• Systemic disease
• History and examination
• Drugs, onset, localised or systemic
Non-drug Treatments
• Discourage scratching – short nails
• Avoid hot baths, overheating and sweating
• Pat skin dry! Cool cotton clothes!
• Avoid alcohol and spicy foods
Skin Care
• Emollient – aqueous cream & menthol
• Calamine lotion - ?still recommended
• Barrier cream
• Consider hydrocortisone
• NB Eurax and topical antihistamines
Systemic Disorders
• Renal failure• Hepatogenic • Haematopoietic• Endocrine• Solid tumours• HIV
• Opiod induced• Neurogenic• Aquagenic• Inatrogenic• Senile• Psychogenic
Chronic Renal Failure
• Aetiology– Dry skin– Hyperparathyroidism– Mast cell proliferation– Loss opiod receptors and increased endogenous
opiods
• Peripheral neuropathy
• Increased – Histamine– Vitamin A– Magnesium, phosphate, aluminium– Serotonin– Substance P
Hepatogenic Pruritus
• PBC
• drug induced cholestasis– Oral contraceptive, phenothiazines
• Biliary obstruction
Aetiology
• ? Bile acids
• ? Accumulation pruritogen intermediary
• ? Histamine induced
• ? Centrally activated pruritogenic opiod
• ? Increased serotonin
Haematopoietic Disorders
• PCV– Increased histamine
• Hodgkins• Others
– ? Histamine– ? Autoimmune response– ? Infiltration – ? Release of leukopeptidase
Endocrine Disorders
• Thyrotoxicosis – ? Activate kinins– ? Reduced itch threshold
• Hypothyroidism– xerosis
• Diabetes mellitus– candida
Solid Tumours
• Paraneoplastic
• ? Allergic reaction to Ag
• ? Toxic products of necrotic tumour cells
• Breast, stomach, lung, prostrate, colon
Opiod Induced Pruritus
• Spinal > systemic
• Peripheral – stimulate release histamine
• Central – cephalad spread in CSF
• Bupivicaine given
• ? Role serotoninergic pathways
• ? Antagonism of inhibitory transmitters
• Opiod rotation
Inatrogenic Pruritus
• Aspirin
• Hydroxyurea
• Captopril
• Antibiotics
• Phenytoin
• Allopurinol
Neurogenic
• Neuropathies– E.g. multiple sclerosis– Activation artificial synapses
• Unilateral cerebral lesions– Effects on descending pathways
• Post-herpetic neuralgia
Senile Pruritus
• Xerosis
• Skin atropy
• ? Age associated degeneration in nerve endings
• ? Postmenopausal syndrome
Psychogenic Pruritus
• Feelings of hopelessness / helplessness
• Secretion serotonin, dopamine
• Elevated endogenous opiods
• ? ‘depressive equivalent’
Others
• HIV• High prevalence skin
disorders• Abnormal levels
cytokines• Hypereosinophilia• Peripheral neuropathy
• AQUAGENIC• Contact with water• Pathogenesis unknown
Specific Treatments
• Anti-inflammatory agents– Antihistamines
(cimetidine)
– Steroids
– Salicylates (capsacin)
– Thalidomide
• Central / peripheral nervous system agents– Antidepressants
– Anaesthetic agents
– Opiod antagonists
– Serotonin antagonists
– Neuroleptic agents
– Tranquillizers
Specific treatments
• Sequestrants– Cholestyramine
– Charcoal
– Heparin
• Vaso-active drugs– Alpha blockers
– Beta blockers
Disease Specific Interventions
• Cholestatic disease– Rifampicin
– Androgens
– Urso
– Stenting
• Uraemia– Erythropoitin
– UVB phototherapy
– Parathyroidectomy
– Transplantation
Disease Specific Interventions
• PCV – alpha interferon
• Fe deficiency – iron• Thyroid disorder
Miscellaneous
• Phototherapy
• TENS
• Acupuncture
• Psychotherapy
• Relaxation
Problems in Palliative Medicine
• Most terminal phase
• Changing organ function
• Systemic treatment may be toxic, impractical
Conclusions
• Pathophysiology not fully understood
• Peripheral and central mechanisms
• Often associated with systemic diseases
Conclusions
• Importance of non-pharmacological treatment
• Treat what is treatable
• Rare problem but impact on quality of life
• Likely that older drugs will be used
• Await our protocol review!
References
• Understanding pruritus in systemic disease– Journal Pain & Symptom Management 2001
• Pathophysiology of itching– Lancet 1996
• Oxford textbook of Palliative Medicine, Symptom Management in Advanced Cancer,Advanced Course in Pain & Symptom Management
Antihistamines
• Useful where histamine release has role
• E.g. allergic rhinoconjunctivitis
• Lack activity in CRF, haematopoitic disorders, opiod induced
• Pizotifen (antiserotoninergic action)
• Sedating doses e.g. hydroxyzine
Capsaicin
• Anti-inflammatory
• Reduces substance P from nerve endings
• Inhibits itch transmission
• Use : localised pruritus e.g. uraemia
Thalidomide
• Reduce TNF synthesis
• Anti-inflammatory
• ? Interfere with cytokine production
• Use : uraemia
Cimetidine
• Role not established
• Enhance effect anti-histamines
• Use : uraemia
haematological malignancies
Antidepressants
• Signs depression / anxiety
• Failure to respond to standard therapy
• Tricyclics (doxepin)– Antidepressant, antihistamine, sedative
• SSRI (paroxetine)– Down-regulation post-synaptic receptors– Reduce serotonin – receptor interaction
Role
• CRF
• Haematological malignancies
• Depressive disorders
• Neuroleptics / benzodiazepine use
5-HT3 Antagonists
• Ondansetron
• Serotonin mediator of itch
• Use : cholestasis, uraemia, spinal opiods
• Expensive
• Often IV use
Opiod Antagonists
• Counteract endogenous opiods
• Can be impractical
• Naltrexone (oral preparation)
• Use : CRF, hepatogenic & haematological pruritus
• ‘opiod abstinence syndrome’
• Buprenorphine
• Partial agonist
• Nalbuphine
• Mixed agonist-antagonist
• Needs further evaluation
• Opiod rotation
Anaesthetic Agents
• Lignocaine
• Abnormal pattern cutaneous innervation
• Associated peripheral neuropathy
• Use : uraemia
• Toxic adverse effects
• Propofol
• Subhypnotic doses in hepatogenic pruritus
• Opiod induced– ? Inhibit dorsal root transmission– ? Blocks
Sequestrants
• Cholestyramine
• Reduce bile acids
• Remove other pruritogens
• Use : cholestasis
• Unpalatable
• Diarrhoea
• Charcoal
• Use : uraemia
• ?chelates metabolites
• Heparin
Disease Specific Drugs
• Uraemia
• Erythropoietin
• UVB phototherapy
• Parathyroidectomy
• Transplantation
Disease Specific Drugs
• Cholestatic disease
• Androgens– Stanazol, methytestosterone
• Rifampicin
• Biliary stenting definitive treatment
Ultraviolet Light
• UVB
• Reduce content vitamin A
• Inhibit release histamine & proliferation mast cells
• Use : renal and liver disease, AIDS
• PUVA
• Ultrastructural changes in nerves
• Increase sensory thresholds
• Reduce end-organ responsiveness
• ? Stabilise mast cells
• Use : pruritic dermatoses
Others
• TENS– Induction on ‘lateral inhibition’ in spinal cord
• Acupuncture
• Plasma exchange
• Psychotherapy
• Relaxation